A Comparison of Outcomes with Angiotensin-Converting-Enzyme Inhibitors and Diuretics for the Treatment of Hypertension in the Elderly

dc.contributor.authorWing, Lindon M. H.
dc.contributor.authorReid, Christopher M
dc.contributor.authorRyan, P A
dc.contributor.authorBeilin, Lawrence J.
dc.contributor.authorBrown, Mark A.
dc.contributor.authorJennings, Garry L R
dc.contributor.authorJohnston, Colin I
dc.contributor.authorMcNeil, John J
dc.contributor.authorMacdonald, Graham J
dc.contributor.authorMarley, John E.
dc.contributor.authorMorgan, Trefor O.
dc.contributor.authorMoore, Shane
dc.contributor.authorChalmers, John
dc.contributor.authorWhitworth, Judith
dc.date.accessioned2015-12-13T22:35:08Z
dc.date.available2015-12-13T22:35:08Z
dc.date.issued2003
dc.date.updated2015-12-11T09:26:01Z
dc.description.abstractBACKGROUND: Treatment of hypertension with diuretics, beta-blockers, or both leads to improved outcomes. It has been postulated that agents that inhibit the renin-angiotensin system confer benefit beyond the reduction of blood pressure alone. We compared
dc.identifier.issn0028-4793
dc.identifier.urihttp://hdl.handle.net/1885/76452
dc.publisherMassachusetts Medical Society
dc.sourceNew England Journal of Medicine
dc.subjectKeywords: beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; age distribution; aged; article; blood pressure measurement; blood pressure regulation; cardiovascular disease; cardiovascular risk; clinical trial; comparativ
dc.titleA Comparison of Outcomes with Angiotensin-Converting-Enzyme Inhibitors and Diuretics for the Treatment of Hypertension in the Elderly
dc.typeJournal article
local.bibliographicCitation.issue7
local.bibliographicCitation.lastpage592
local.bibliographicCitation.startpage583
local.contributor.affiliationWing, Lindon M. H., Flinders University
local.contributor.affiliationReid, Christopher M, Baker Heart Research Institute
local.contributor.affiliationRyan, P A, Queensland Institute of Medical Research
local.contributor.affiliationBeilin, Lawrence J., University of Western Australia
local.contributor.affiliationBrown, Mark A., University of New South Wales
local.contributor.affiliationJennings, Garry L R, Baker Heart Research Institute
local.contributor.affiliationJohnston, Colin I, Baker Heart Research Institute
local.contributor.affiliationMcNeil, John J, Monash University
local.contributor.affiliationMacdonald, Graham J, Merck Sharp and Dohme (Australia) Pty. Ltd.
local.contributor.affiliationMarley, John E., University of Newcastle
local.contributor.affiliationMorgan, Trefor O., University of Melbourne
local.contributor.affiliationMoore, Shane, Commonwealth Department of Defence
local.contributor.affiliationChalmers, John, Royal Prince Alfred Hospital
local.contributor.affiliationWhitworth, Judith, College of Medicine, Biology and Environment, ANU
local.contributor.authoremailu9910403@anu.edu.au
local.contributor.authoruidWhitworth, Judith, u9910403
local.description.notesImported from ARIES
local.description.refereedYes
local.identifier.absfor110201 - Cardiology (incl. Cardiovascular Diseases)
local.identifier.ariespublicationMigratedxPub5255
local.identifier.citationvolume348
local.identifier.doi10.1056/NEJMoa021716
local.identifier.scopusID2-s2.0-0037434556
local.identifier.uidSubmittedByMigrated
local.type.statusPublished Version

Downloads